| Title |
Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso
|
|---|---|
| Published in |
Drug Design, Development and Therapy, April 2020
|
| DOI | 10.2147/dddt.s224857 |
| Pubmed ID | |
| Authors |
Toussaint Rouamba, Paul Sondo, Karim Derra, Seydou Nakanabo-Diallo, Biebo Bihoun, Eli Rouamba, Zekiba Tarnagda, Adama Kazienga, Innocent Valea, Hermann Sorgho, Franco Pagnoni, Fati Samadoulougou-Kirakoya, Halidou Tinto |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 60 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 13 | 22% |
| Student > Postgraduate | 3 | 5% |
| Student > Ph. D. Student | 3 | 5% |
| Student > Doctoral Student | 2 | 3% |
| Student > Bachelor | 2 | 3% |
| Other | 6 | 10% |
| Unknown | 31 | 52% |
| Readers by discipline | Count | As % |
|---|---|---|
| Nursing and Health Professions | 8 | 13% |
| Medicine and Dentistry | 4 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Social Sciences | 2 | 3% |
| Agricultural and Biological Sciences | 2 | 3% |
| Other | 7 | 12% |
| Unknown | 35 | 58% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2024.
All research outputs
#8,152,094
of 25,870,940 outputs
Outputs from Drug Design, Development and Therapy
#557
of 2,287 outputs
Outputs of similar age
#154,301
of 399,098 outputs
Outputs of similar age from Drug Design, Development and Therapy
#9
of 37 outputs
Altmetric has tracked 25,870,940 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 2,287 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 399,098 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.